Quang Pham has served as our Chief Executive Officer since he formed the Company in 2022. He previously served as Chairman & CEO of Espero BioPharma, Inc., a company he also founded and the previous sponsor of the tecarfarin IND. He then served as a consultant to HESP LLC, the assignee for Espero to Horizon Technology Finance. Previously, Mr. Pham was a partner with D+R LATHIAN, LLC, a life sciences multichannel marketing agency. Prior to joining D+R LATHIAN, he founded and served as Chairman and CEO of Lathian Systems, Inc., a digital and database marketing company serving the pharmaceutical industry until 2012 when the company was acquired by D&R Communications, LLC. He has a Bachelor of Arts in Economics from UCLA, and served as a U.S. Marine Corps Officer. We believe Mr. Pham is qualified to serve on our Board of Directors because of his significant business, mergers and acquisitions, and fundraising experience, numerous interactions with the FDA, continuous five-year history with tecarfarin development, and his extensive knowledge of the pharmaceutical industry and our competitors.